André Rogatko

8.9k total citations
170 papers, 6.2k citations indexed

About

André Rogatko is a scholar working on Oncology, Molecular Biology and Statistics and Probability. According to data from OpenAlex, André Rogatko has authored 170 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 35 papers in Molecular Biology and 33 papers in Statistics and Probability. Recurrent topics in André Rogatko's work include Statistical Methods in Clinical Trials (31 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Colorectal Cancer Treatments and Studies (13 papers). André Rogatko is often cited by papers focused on Statistical Methods in Clinical Trials (31 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Colorectal Cancer Treatments and Studies (13 papers). André Rogatko collaborates with scholars based in United States, Brazil and France. André Rogatko's co-authors include James S. Babb, Murray F. Brennan, Mourad Tighiouart, Shelemyahu Zacks, Louis M. Weiner, AD Auerbach, R. Katherine Alpaugh, Neal J. Meropol, Steven J. Cohen and Jonathan D. Cheng and has published in prestigious journals such as New England Journal of Medicine, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

André Rogatko

162 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Rogatko United States	43	2.6k	1.9k	1.0k	1.0k	919	170	6.2k
Mourad Tighiouart United States	38	1.7k 0.7×	1.6k 0.9×	700 0.7×	930 0.9×	573 0.6×	152	5.0k
B. Nebiyou Bekele United States	56	3.8k 1.4×	3.9k 2.0×	1.4k 1.4×	3.3k 3.2×	628 0.7×	137	10.3k
Sumithra J. Mandrekar United States	47	4.3k 1.7×	1.8k 0.9×	1.4k 1.3×	3.4k 3.3×	1.2k 1.3×	213	9.4k
Christophe Le Tourneau France	46	4.9k 1.9×	2.1k 1.1×	1.6k 1.5×	2.3k 2.2×	580 0.6×	335	8.7k
S. Percy Ivy United States	43	3.6k 1.4×	4.1k 2.2×	1.3k 1.2×	1.3k 1.3×	399 0.4×	189	7.9k
Barbara A. Conley United States	39	2.7k 1.0×	2.3k 1.2×	1.3k 1.3×	1.5k 1.4×	318 0.3×	143	6.0k
Rajeshwari Sridhara United States	53	4.8k 1.8×	3.0k 1.6×	1.3k 1.3×	2.9k 2.8×	484 0.5×	137	9.3k
Zhengjia Chen United States	51	3.1k 1.2×	2.4k 1.3×	989 0.9×	2.5k 2.4×	131 0.1×	267	8.3k
David R. Spriggs United States	62	4.9k 1.9×	4.2k 2.2×	1.2k 1.2×	1.9k 1.8×	232 0.3×	230	13.0k
Shenghui Tang United States	39	2.9k 1.1×	1.2k 0.6×	855 0.8×	1.8k 1.8×	269 0.3×	116	5.3k

Countries citing papers authored by André Rogatko

Since Specialization

Citations

This map shows the geographic impact of André Rogatko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Rogatko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Rogatko more than expected).

Fields of papers citing papers by André Rogatko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Rogatko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Rogatko. The network helps show where André Rogatko may publish in the future.

Co-authorship network of co-authors of André Rogatko

This figure shows the co-authorship network connecting the top 25 collaborators of André Rogatko. A scholar is included among the top collaborators of André Rogatko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Rogatko. André Rogatko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gresham, Gillian, Michael Luu, N. Lynn Henry, et al.. (2025). Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization Tool. JCO Clinical Cancer Informatics. 9(9). e2400109–e2400109. 1 indexed citations

Gresham, Gillian, N. Lynn Henry, Hanna Bandos, et al.. (2025). Analyses of adverse events and patient‐reported outcomes with the toxicity index in cancer clinical trials. Cancer. 131(S2). e70086–e70086.

Luu, Michael, Gillian Gresham, N. Lynn Henry, et al.. (2024). Development of a Web-Based Interactive Tool for Visualizing Breast Cancer Clinical Trial Tolerability Data. JCO Clinical Cancer Informatics. 8(8). e2400007–e2400007. 3 indexed citations

Tighiouart, Mourad & André Rogatko. (2024). Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels. Entropy. 26(8). 687–687.

Calsavara, Vinícius F., N. Lynn Henry, Ron D. Hays, et al.. (2023). Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial. Cancer Prevention Research. 16(11). 631–639. 3 indexed citations

Ganz, Patricia A., Ron D. Hays, Karen L. Spritzer, et al.. (2022). Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04. Cancer. 128(17). 3233–3242. 6 indexed citations

Henry, N. Lynn, Sungjin Kim, Ron D. Hays, et al.. (2022). Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30. npj Breast Cancer. 8(1). 123–123. 6 indexed citations

Henry, N. Lynn, Sungjin Kim, Ron D. Hays, et al.. (2021). Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35. Journal of Clinical Oncology. 39(34). 3800–3812. 14 indexed citations

Gresham, Gillian, Márcio A. Diniz, Michael Luu, et al.. (2020). Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index. JNCI Journal of the National Cancer Institute. 112(12). 1266–1274. 28 indexed citations

10.

Crosby, Erika J., William R. Gwin, Kimberly Blackwell, et al.. (2019). Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study. Clinical Cancer Research. 25(9). 2725–2736. 54 indexed citations

11.

Wei, Janet, Louise Thomson, John W. Petersen, et al.. (2015). ANGINA AND MYOCARDIAL PERFUSION IMPROVE IN WOMEN WITH CORONARY MICROVASCULAR DYSFUNCTION AT 1 YEAR FOLLOW-UP: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION. Journal of the American College of Cardiology. 65(10). A1579–A1579. 1 indexed citations

12.

Josson, Sajni, Murali Gururajan, Peizhen Hu, et al.. (2014). miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer. Clinical Cancer Research. 20(17). 4636–4646. 118 indexed citations

13.

Chu, Gina Chia‐Yi, Haiyen E. Zhau, Ruoxiang Wang, et al.. (2014). RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocrine Related Cancer. 21(2). 311–326. 68 indexed citations

14.

Jones, Erika, Janet Wei, Puja K. Mehta, et al.. (2014). B-TYPE NATRIURETIC PEPTIDE DOES NOT CORRELATE WITH INVASIVE OR NONINVASIVE MEASURES OF CORONARY MICROVASCULAR DYSFUNCTION IN WOMEN WITH PRESERVED EJECTION FRACTION: A REPORT FROM THE WOMEN'S ISCHEMIA SYNDROME EVALUATION- CORONARY VASCULAR DYSFUNCTION (WISE-CVD) STUDY. Journal of the American College of Cardiology. 63(12). A1411–A1411. 3 indexed citations

15.

Parker, Kathy P., Donald L. Bliwise, Maria H.L. Ribeiro, et al.. (2008). Sleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography. Journal of Clinical Oncology. 26(15). 2464–2472. 86 indexed citations

16.

Cohen, Steven J., R. Katherine Alpaugh, Steve Gross, et al.. (2006). Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 6(2). 125–132. 157 indexed citations

17.

Borghaei, Hossein, Michael Millenson, Russell J. Schilder, et al.. (2004). Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non‐Hodgkin lymphoma. Cancer. 101(9). 2034–2041. 3 indexed citations

18.

Cheng, Jonathan D., Roland L. Dunbrack, Matthildi Valianou, et al.. (2002). Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.. PubMed. 62(16). 4767–72. 198 indexed citations

19.

Rebbeck, Timothy R., André Rogatko, & Marios A. G. Viana. (1997). Evaluation of Genotype Data in Clinical Risk Assessment: Methods and Application to BRCA1, BRCA2 , and N-Acetyl Transferase-2 Genotypes in Breast Cancer. Genetic Testing. 1(3). 157–164. 7 indexed citations

20.

Rogatko, André. (1992). Bayesian approach for meta - analysis of controlled clinical trials. Communication in Statistics- Theory and Methods. 21(5). 1441–1462. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact